← FDA Drug Approvals (Drugs@FDA)

DECITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2020-12-07

Drug application

FDA Application #

ANDA212117

Application type

Abbreviated New Drug Application (Generic)

Brand name

DECITABINE

Generic name

DECITABINE

Active ingredients

DECITABINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

NIVAGEN PHARMS INC

Manufacturer

Nivagen Pharmaceuticals, Inc.

First approval

2020-12-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown